ÂÜÀòÂÒÂ×

Hakan Goker is a seasoned professional in biotechnology investments, currently serving as Managing Director at M Ventures since November 2013, overseeing investments in healthcare and life sciences. Goker holds various board member positions, including roles at Ribometrix, Artios Pharma Ltd, Asceneuron SA, iOnctura, STORM Therapeutics Limited, and SynAffix BV. Goker also contributes to strategic discussions as an Advisory Board Member for BioPartner and as Committee Chairman for the Anglo Nordic Biotechnology and Medtech Conference. With a PhD in Molecular Genetics from the University of London and a BSc Hons in Human Genetics from UCL, Goker has extensive expertise in developing innovative therapies and enhancing patient outcomes.